our science
Pipeline

SCROLL DOWN
Pipeline
Pipeline
Program Indication Candidate Discovery Pre-clinical Phase I Phase II
Hit to Lead Lead Optimization
Neuro
degeneration
Alzheimer’s
disease
ATC-102
Tau
Amyolateral
schlerosis
ATC-104
TDP43
Amyloidosis hATTR
amyloidosis
ATC-202
mutant-transthyretin
Desmin
myopathy
ATC-205
Desmin
Cancer Solid tumor ATC-301
pan-RAS
Solid tumor ATC-303
p53
Muscular
Dystrophy
Duchene
muscular
dystrophy
ATC-401
ATE1
Infectious
disease
Multi-drug
resistance/
Sepsis
ATC-503
Bacteria/Virus
Metabolic
diseases
Obesity ATC-601
Lipophagy
Diabetes ATC-602
Lipophagy
Other rare
disease
Zelweger
syndrome
ATC-902
ATE1